Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL JOURNAL SELECTION NETWORK HELP ABOUT

Journal Selection Criteria and Standards

WPRIM Journal Selection Criteria (August 2026)

NJSC Philippines Selection Criteria (for Philippine-based journals only)

Minimum standards for the suspension and removal of WPRIM approved journals

Application and Indexing Process

Application and Submission Process for WPRIM Indexing

Journal Content Management

Candidate Journal Selection and Data Creation and Management System

Chinese Journal of Digestive Surgery

2002  to  Present  ISSN: 1673-9752

Articles

About

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

3164

results

page

of 317

1

Cite

Cite

Copy

Share

Share

Copy

Optimization of immunosuppressive therapy after liver transplantation

Zhanyu YANG ; Tengqian TANG

Chinese Journal of Digestive Surgery.2013;12(9):652-654. doi:10.3760/cma.j.issn.1673-9752.2013.09.004

The toxic effects of immunosuppressants are often dangerous factors which influence long-term survival of recipients.Individualized immunosuppressive therapy has been a hotspot and difficulty for comprehensive treatment of liver transplantation.Immunosuppressive therapy has been gradually developed to pursue long-term survival for receipients and graft,minimized side effects of immunosuppressants,optimized quality of life of patients,and reduce the economic burden of patients.Through consideration of patient's pathophysiological state,understanding the characteristics and side effects of various immunosuppressive,appropriate choose of the immune inhibitor,correct evaluation of immune state of recipients and graft,minimization of drug doses,individualized dosing regimen could be successfully carried out.

2

Cite

Cite

Copy

Share

Share

Copy

Retrograde caudate lobectomy combined with right hemi-hepatectomy

Zhenguang WANG ; Siyuan FU ; Weiping ZHOU ; Mengchao WU

Chinese Journal of Digestive Surgery.2013;12(9):655-658. doi:10.3760/cma.j.issn.1673-9752.2013.09.005

Retrograde caudate lobectomy is a proper technique to resect the tumor in caudate lobe when the tumor is too big or closely adherent to the inferior vena cava.A male patient aged 44 years was admitted to the Eastern Hepatobiliary Surgery Hospital in November 2007.The ligaments around the liver were firstly dissected to mobilize the whole liver,and the right hepatic pedicle was dissected and ligated,then the liver was splited anteriorly along the Cantlie's line.The tumor was opposed in the sight and then it was dissected from the liver parenchyma.The short hepatic veins were ligated and the tumor was detached from the inferior vena cava.The inflow blood was occluded for 19 minutes,and the total blood loss was 4500 ml.The technique of retrograde caudate lobectomy can improve the success rate and safety of caudate lobectomy when the tumor in the caudate lobe is too large or adherent to the inferior vena cava.

3

Cite

Cite

Copy

Share

Share

Copy

Correlated factors of pulmonary metastasis of hepatocellular carcinoma

Yongyi ZENG ; Xiang ZHANG ; Jingfeng LIU ; Yang ZHONG ; Xianming WANG

Chinese Journal of Digestive Surgery.2013;12(9):668-671. doi:10.3760/cma.j.issn.1673-9752.2013.09.008

Objective To investigate the correlated factors of pulmonary metastasis of hepatocellular carcinoma (HCC),so as to provide theoretical evidences for the prevention and treatment.Methods The clinical data of 862 patients with HCC who were admitted to the First Affiliated Hospital of Fujian Medical University from January 2008 to March 2012 were retrospectively analyzed.There were 107 patients with pulmonary metastasis.Factors including serum alpha fetoprotein (AFP) level,serum gamma-glutamyl transpeptidase (GGT) level,hepatitis B virus (HBV) infection,presence and treatment of intrahepatic tumor were analyzed to screen out relevant factors of pulmonary infection of HCC.Univariate and multivariate COX regression model analysis were performed for data analysis.Results The results of univariate analysis showed that high level of AFP (≥400 μg/L),ultra-high level of GGT (≥ 150 U/L),presence of HBV infection,the number of intrahepatic tumors ≥2,no radical resection (or radiofrequency ablation) for intrahepatic tumors,combining with tumor thrombi in the vessels,lymph node metastasis were risk factors of pulmonary metastasis of HCC (RR =1.986,3.653,0.365,3.675,0.252,0.379,0.352,P < 0.05).The results of multivariate analysis showed that high level of AFP (≥400 μg/L),HBV infection,the number of intrahepatic tumors ≥2,no radical resection (or radiofrequency ablation) for intrahepatic tumors,combining with tumor thrombi in the vessels were risk factors of pulmonary metastasis of HCC (RR =2.391,3.462,3.425,3.396,2.418,0.638,P < 0.05).Conclusions AFP ≥400 μg/L,HBV infection,the number of intrahepatic tumors ≥ 2,no radical resection (or radiofrequency ablation),tumor thrombi in the vessels and lymph node metastasis are risk factors of pulmonary metastasis of HCC.Anti-hepatitis virus treatment and early treatment are helpful for the prevention and treatment.

4

Cite

Cite

Copy

Share

Share

Copy

Radiofrequency ablation combined with low frequency ultrasound radiation with microbubble for the treatment of malignant liver neoplasms

Yun JIN ; Zhenzhou WANG ; Ling YANG ; Ding LUO

Chinese Journal of Digestive Surgery.2013;12(9):672-675. doi:10.3760/cma.j.issn.1673-9752.2013.09.009

Objective To investigate the clinical efficacy and safety of radiofrequency ablation (RFA)combined with low frequency ultrasound radiation with microbubble for the treatment of malignant liver neoplasms.Methods The clinical data of 25 patients with malignant liver neoplasms who received RFA combined with low frequency ultrasound radiation with microbubble at the Kunming General Hospital from January 2010 to June 2011 were retrospectively analyzed.RFA was firstly performed with ultrasonic guidance,and then low frequency ultrasound radiation with microbubble was performed according to the results of ultrasound contrast examination 1 week after RFA.Ultrasound contrast examination was performed and the hepatic function and serum alpha fetoprotein (AFP) were assayed before operation,3 and 6 months after operation,respectively.All data were analyzed using the t test or chi-square test.Results The gross tumor volumes of 16 patients reduced by 30% at 3 months after operation when compared with that before operation.The gross tumor volumes of 17 patients reduced by 50% at 6 months after operation when compared with that before operation.The gross tumor volume of 7 patients reduced,but tissues surrounding tumors showed the signal of bloodstream.The gross tumor volume of 1 patient did not reduce.The levels of aspartate aminotransferase (AST),total bilirubin (TBil) and alpha fetoprotein (AFP) at 3 months after operation were significantly lower than those before operation (t =23.51,13.79,257.07,P <0.05).The levels of alanine aminotransferase (ALT),AST,TBil and AFP at 6 months after operation were significantly lower than those before operation (t =5.67,27.19,21.02,333.46,P < 0.05).No local recurrence was detected during a follow-up of 6 months.The scores of quality of life (QOL) were very good in 21 (84.0%) patients,good in 2 (8.0%) patients,fair in 1 (4.0%) patient and poor in 1 (4.0%) patient.The scores of Karnofsky (KPS)were improved in 19 (76.0%) patients,stable in 5 (20.0%) patients and aggravated in 1 (4.0%) patient.There were significant differences in QOL and KPS between pre-and postoperation (x2=41.600,18.960,P <0.05).Conclusion RFA combined with low frequency ultrasound radiation with microbubble is effective in reducing the tumor size and protect the hepatic function for patients with malignant liver neoplasms.

5

Cite

Cite

Copy

Share

Share

Copy

Clinical efficacy of surgical treatment for hilar cholangiocarcinoma: a report of 207 cases

Hangyang YE ; Dajiang LI ; Yu HE ; Zhihua LI ; Ping BIE ; Zhanyu YANG ; Shuguang WANG

Chinese Journal of Digestive Surgery.2013;12(9):692-697. doi:10.3760/cma.j.issn.1673-9752.2013.09.013

Objective To investigate the efficacy of different radical surgical procedures for the treatment of hilar cholangiocarcinoma.Methods The clinical data of 207 patients with hilar cholangiocarcinoma who were treated at the Southwest Hospital from June 2007 to June 2012 were retrospectively analyzed.Local resection or hemihepatectomy combined with caudate lobectomy was applied to patients with Bismuth type Ⅰ hilar cholangiocarcinoma; dumbbell type radical resection was applied to patients with Bismuth type Ⅱ hilar cholangiocarcinoma or some patients with type Ⅲ a,Ⅲ b and Ⅳ hilar cholangiocarcinoma; hemihepatectomy or extended hemihepatectomy combined with caudate lobectomy was applied to patients with Bismuth type Ⅲ a,Ⅲ b and Ⅳ hilar cholangiocarcinoma.The patients were followed up every 3 months postoperatively till December 2012.All data were analyzed using the chi-square test or Fisher exact probability test,the survival curve was drawn by Kaplan-Meier method,and the survival was analyzed using the Log-rank test.Results Of the 207 patients,124 received radical resection,including 14 received local resection,23 received dumbbell type resection,87 received lobectomy + caudate lobectomy,49 received palliative resection; 34 received biliary drainage.Four patients died perioperatively.The incidences of complications of dumbbell type radical resection,left hemihepatectomy + caudate lobectomy,right hemihepatectomy + caudate lobectomy were 21.7% (5/23),46.6% (27/58) and 48.3% (14/29),respectively.The incidence of complications after dumbbell type radical resection was significantly lower than left hemihepatectomy + caudate lobectomy and right hemihepatectomy + caudate lobectomy (x2 =4.42,3.90,P < 0.05).One hundred and seventy patients were followed up.The median survival time of the 112 patients who received radical radical resection was 26.5 months,and the 1-,3-,5-year survival rates were 75.9% (85/112),42.9% (24/56) and 28.9% (11/38),respectively.The median survival time of the 38 patients who received palliative resection was 8.5 months,and the 1-,3-year survival rates were 31.6% (12/38) and 0.The survival time of 20 patients who received biliary drainage was 4.0 months,and the l-year survival rate was 0.The survival rate of patients who received radical resection was significantly higher than those who received palliative resection (x2=65.32,P < 0.05).There was a significant difference in the survival rate between patients who received surgical treatment and those who received biliary drainage (x2=99.97,P < 0.05).Of the 112 patients who received radical resection,the median survival time of 10 patients who received local resection of tumor was 47.0 months,the 1-year survival rate was 10/10,and 4 patients survived at the end of the follow-up; the median survival time of 23 patients who received dumbbell type radical resection was 32.0 months,and the 1-,3-year survival rates were 95.7% (22/23) and 7/15,and the survival time of 6 patients was longer than 5 years; the median survival time of 54 patients who received left hemihepatectomy or extended left hemihepatectomy + caudate lobectomy was 27.6 months,and the 1-,3-year survival rates were 42.1% (24/57) and 38.7% (12/32),and the survival time of 9 patients was longer than 5 years,3 patients survived at the end of the follow-up ; the median survival time of 25 patients who received right hemihepatectomy or extended right hemihepatectomy + caudate lobectomy was 28.3 months,and the 1-,3-year survival rates were 45.8% (11/24) and 6/15,and the survival time of 6 patients was longer than 5 years,2 patients survived at the end of follow-up.The median survival time of 35 patients (patients with Bismuth type Ⅰ,Ⅱ hilar cholangiocarcinoma and Bismuth Ⅲ a and Ⅲ b hilar cholangiocarcinoma which did not invade the secondary bile duct) who received hemihepatectomy + caudate lobectomy was 32.0 months,and the 1-,3-,5-year survival rates were 91.4% (32/35),45.8% (11/24) and 5/16,which were not different from the survival rate of patients who received dumbbell type radical resection (x2 =0.17,P > 0.05).The 5-year survival rate of patients with lymph node metastasis was 4/19,which was significantly lower than 30.4% (7/23) of patients without lymph node metastasis (x2 =23.40,P < 0.05).Conclusion Joint lobectomy and standardized lymph node dissection could help to improve the efficacy of surgical treatment for patients with hilar cholangiocarcinoma.

6

Cite

Cite

Copy

Share

Share

Copy

Value of percutaneous transhepatic cholangiobiopsy in the diagnosis of obstructive jaundice

Zhen LI ; Tengfei LI ; Jinxue ZHOU ; Xinwei HAN

Chinese Journal of Digestive Surgery.2013;12(9):698-702. doi:10.3760/cma.j.issn.1673-9752.2013.09.014

Objective To investigate the value of percutaneous transhepatic cholangiobiopsy (PTCB) in the diagnosis of obstructive jaundice.Methods The clinical data of 826 patients with obstructive jaundice who received PTCB at the First Affiliated Hospital of Zhengzhou University from April 2001 to December 2011 were retrospectively analyzed.The pathological results,positive rates of PTCB and complications were analyzed.The safety and efficacy of PTCB and the pathological features of malignancy causing obstructive jaundice were summarized.The difference in the positive rates of PTCB for biliary and non-biliary malignancies was analyzed by chi-square test.Results A total of 826 patients received PTCB,and the success rate was 100%.Eighty-six patients had complications postoperatively,including transit bilhaemia in 47 patients,bile leakage in 11 patients,temporary biliary hemorrhage in 28 patients,no severe complications occurred.There were 740 patients were with malignant biliary stricture and 86 with benign biliary stricture.Seven Hundred and twenty-seven patients were with positive results of PTCB (641 were with cancerous stricture and 86 with inflammation of biliary tract or fibrogenesis),and 99 patients were with false negative results.The overall positive rate of PTCB was 88.01% (727/826).Malignant neoplasm accounted for 89.59% (740/826) of the factors causing obstructive jaundice,and well-,moderate-and poor-differentiated neoplasms were accounted for 57.88% (371/641),19.97% (128/641) and 22.15% (142/641).Biliary adenocarcinoma was the main pathologic type,which was accounted for 96.41% (618/641).The positive rates of PTCB for biliary and non-biliary neoplasms were 89.50% (469/524)and 79.63% (172/216),with significant difference (x2 =12.87,P < 0.05).Conclusions PTCB is a safe,feasible and easy way to diagnose obstructive jaundice.Biliary neoplasms are the best indications for PTCB.Well differentiated neoplasm is the main pathological type causing the obstructive jaundice.

7

Cite

Cite

Copy

Share

Share

Copy

Points for attention in minimally invasive esophagectomy

Ruwen WANG

Chinese Journal of Digestive Surgery.2013;12(10):731-733. doi:10.3760/cma.j.issn.1673-9752.2013.10.001

Esophageal cancer is ranked the eighth most common cancer worldwide,which severely threatens the health of human beings.Radical esophagectomy and regional lymphadenectomy through open approach offer the standard management for patients with locoregional disease,but it is associated with significant postoperative morbidity and mortality.It has been reported that minimally invasive esophagectomy (MIE) is associated with a substantial decrease in blood loss,complication rate and duration of hospital stay,and the resection rate,lymph node dissection and postoperative mortality were comparable to those of traditional open surgery.In this article,current views related to indications and contraindications,surgical options,operative positions,prevention of postoperative complications,as well as learning curve of MIE were discussed so as to promote the popularization of MIE.

8

Cite

Cite

Copy

Share

Share

Copy

Current situation of and thoughts on the minimally invasive esophageal surgery

Hui LI ; Ye ZHANG

Chinese Journal of Digestive Surgery.2013;12(10):734-736. doi:10.3760/cma.j.issn.1673-9752.2013.10.002

Esophageal cancer is one of the most common malignancies in the world.Surgical treatment is the first choice for the treatment of esophageal cancer because it could radically resect the tumor and significantly improve the patients'condition.Minimally invasive esophagectomy (MIE) was rapidly developed because of its advantages of minimal invasion,small volume of blood loss,slight pain,low complication rate and quick recovery of patients.The extent of lymphadectomy and postoperative survival rate of MIE were comparable to those of traditional thoracotomy.MIE has become the treatment of choice for benign esophageal diseases and early esophageal cancer in some medical centers.However,debate still exists regarding the role of MIE in the treatment of esophageal cancer,particularly given the limitations in the widespread implementation of this technically challenging operation.This review summarized the current status of the use of minimally invasive surgery for the treatment of esophageal cancer and some thoughts on the development of MIE were provoked.

9

Cite

Cite

Copy

Share

Share

Copy

Laparoscopic vagal-sparing esophagogastrectomy

Taiqian GONG ; Mengbin LI ; Xiaonan LIU ; Li SUN ; Fan YANG ; Ruwen WANG ; Yaoguang JIANG

Chinese Journal of Digestive Surgery.2013;12(10):742-745. doi:10.3760/cma.j.issn.1673-9752.2013.10.004

Laparoscopic vagal-sparing esophagogastrectomy for the treatment of early esophageal cancer has the advantages of minimal invasion,functional sparing and better quality of life,and it can radically resect the tumor.The clinical data of 3 patients in the Daping Hospital of Third Military Medical University and 9 patients in the Xijing Hospital of Digestive Diseases who received laparoscopic vagal-sparing esophagogastrectomy from September 2009 to August 2013 were retrospectively analyzed.All the 12 patients were followed up for 1-24 months.One patient was complicated with transit hoarseness and 1 with cervical anastomotic fistular,and they were cured by conservative treatment; 1 patient was complicated with cervical anastomotic stricture,and was cured by dilatation for 3 times; no dysphagia and recurrence was observed in the other 9 patients during the follow-up.Laparoscopic vagal-sparing esophagogastrectomy is a good option for early esophageal cancer and benign esophageal diseases.

10

Cite

Cite

Copy

Share

Share

Copy

Multiple primary carcinomas including esophageal basaloid squamous cell carcinoma and gastric adenocarcinoma

Hongxia WANG ; Hao CHEN ; Yucheng LIU ; Ling BAI ; Congying YANG ; Rong YAN ; Yajun JIANG

Chinese Journal of Digestive Surgery.2013;12(10):746-749. doi:10.3760/cma.j.issn.1673-9752.2013.10.005

Synchronous multiple primary carcinomas refers to 2 or more than 2 kinds of different primary malignant tumors develop synchronously or in 6 months.The incidence of synchronous multiple primary carcinoma is low.A patient with esophageal basaloid squamous cell carcinoma (BSCC) and gastric adenocarcinoma was admitted to the First People's Hospital of Lianyungang in October 2011.The main symptom of this patient was dysphagia,and multiple lesions were found in esophagus,cardia and stomach fundus by gastroscopy respectively.On computed tomography image,eminence lesion in esophageal midpiece and wall thickening from esophagus-cardia to stomach fundus were displayed and were both enhanced slightly by enhancement scanning.The esophageal and cardia tumors were resected via left thoracic approach,and postoperative pathological examination revealed esophageal BSCC and moderately differentiated adenocarcinoma of cardia respectively.Comedo necrosis and red basal membrane material were seen under light microscope.The expressions of cytokeratin 5/6 and P63 were positive,the expression of cytokeratin L was weak positive and the expressions of synaptophysin,chromogranin A and CD117 were negative.The patient suffered from pleural effusion and multiple liver metastases after 4 months follow-up and died of liver metastases in May 2012.Multiple primary carcinomas including esophageal BSCC and gastric adenocarcinoma are rarely seen in clinical practice.Their diagnosis and differential diagnosis mainly depend on histological morphology and immunohistochemical method.Surgical resection combined with postoperative radiotherapy and chemotherapy is selectable,but the prognosis is poor.

Country

China

Publisher

中华医学会

ElectronicLinks

http://www.zhxhwk.com/

Editor-in-chief

E-mail

digsurg@263.net

Abbreviation

Chinese Journal of Digestive Surgery

Vernacular Journal Title

中华消化外科杂志

ISSN

1673-9752

EISSN

Year Approved

2008

Current Indexing Status

Currently Indexed

Start Year

2002

Description

历史沿革【现用刊名:中华消化外科杂志;曾用刊名:消化外科;创刊时间:2002】,该刊被以下数据库收录【CA 化学文摘(美)(2009)】。

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.